PTCy/Tac/MMF gives a higher 1-year GVHD/relapse or progression-free survival compared to Tac/MTX in graft-versus-host disease 

Effective treatment of low risk acute GVHD with itacitinib monotherapy

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

Maximising cancer treatment and research through omics, data sharing, and open science

Epidemiology, detection, and management of NAFLD: a Latin American perspective

Optimisation of supportive, palliative and end of life care

Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma

What is required to advance data ethics, data sharing, and Open Science across LMICs

Zanubrutinib improves PFS compared to ibrutinib for R/R chronic lymphocytic leukaemia and small lymphocytic lymphoma

Add-on parsaclisib demonstrates improvement in symptoms and SV in MV patients having a suboptimal response to ruxolitinib

A genomic assay may predict long-term prognosis in premenopausal patients with HR+ early-stage breast cancer

Consolidation therapy with blinatumomab improves OS in newly diagnosed patients with B-Lineage ALL in MRD negative remission